Bloom Burton Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Bloom Burton
Rating: 2.6
Author: MarketBeat

View the latest stock recommendations issued by analysts at Bloom Burton. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Bloom Burton's equity research team. MarketBeat is not affiliated with or endorsed by Bloom Burton.

Updated 11/21/2025

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 5 Last 12 Months
Buy Ratings: 3 Last 12 Months
Sell Ratings: 0 Last 12 Months
Companies Covered: 5 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
RX BioSyent	C$13.86 +0.2%	11/21/2025		Upgrade		Moderate Buy ➝ Strong-Buy	View details for Bloom Burton rating of BioSyent (CVE:RX) on 11/21/2025
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	11/5/2025		Downgrade		Moderate Buy ➝ Hold	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/5/2025
XENE Xenon Pharmaceuticals	$53.72 +2.7%	10/7/2025		Upgrade		Strong-Buy	View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 10/7/2025
CNVI Conavi Medical	C$0.29	7/6/2025	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Strong-Buy	View details for Bloom Burton rating of Conavi Medical (CVE:CNVI) on 7/6/2025
MBX Microbix Biosystems	C$0.27	6/5/2025	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Strong-Buy ➝ Moderate Buy	View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/5/2025
MBX Microbix Biosystems	C$0.27	1/4/2024	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 1/4/2024
ABCL AbCellera Biologics	$5.77 -5.9%	11/3/2023	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 11/3/2023
MDP Medexus Pharmaceuticals	C$3.91	6/26/2023	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Buy	View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 6/26/2023
RX BioSyent	C$13.86 +0.2%	3/23/2023	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/23/2023
DOC CloudMD Software & Services	C$0.04	11/16/2022	P. Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Accumulate	View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 11/16/2022
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
DOC CloudMD Software & Services	C$0.04	8/24/2022	P. Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Hold	View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 8/24/2022
MDNA Medicenna Therapeutics	C$0.43 +2.4%	8/16/2022		Lower Price Target	C$9.00	Buy	View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 8/16/2022
MDNA Medicenna Therapeutics	C$0.43 +2.4%	7/28/2022		Reiterated Rating	C$11.00	Buy	View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 7/28/2022
HLS HLS Therapeutics	C$4.40 -0.9%	7/26/2022		Reiterated Rating	C$22.00	Buy	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/26/2022
MBX Microbix Biosystems	C$0.27	6/6/2022	A. Borovina Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Microbix Biosystems (TSE:MBX) on 6/6/2022
MRV Nuvo Pharmaceuticals	C$49.50 +4.2%	5/13/2022	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Hold	View details for Bloom Burton rating of Nuvo Pharmaceuticals (TSE:MRV) on 5/13/2022
GUD Knight Therapeutics	C$8.20	3/28/2022	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	C$6.70	Buy	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/28/2022
GUD Knight Therapeutics	C$8.20	3/25/2022	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Accumulate	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/25/2022
RX BioSyent	C$13.86 +0.2%	3/10/2022	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Accumulate	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/10/2022
DOC CloudMD Software & Services	C$0.04	12/22/2021	P. Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of CloudMD Software & Services (CVE:DOC) on 12/22/2021
ABCL AbCellera Biologics	$5.77 -5.9%	12/19/2021	A. Borovina Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of AbCellera Biologics (NASDAQ:ABCL) on 12/19/2021
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	10/1/2021	Prasath Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$23.00	Hold	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/1/2021
MDNA Medicenna Therapeutics	C$0.43 +2.4%	9/22/2021	Prasath Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	C$11.00	Buy	View details for Bloom Burton rating of Medicenna Therapeutics (TSE:MDNA) on 9/22/2021
HLS HLS Therapeutics	C$4.40 -0.9%	8/5/2021	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/5/2021
VMD Viemed Healthcare	$9.45 -0.3%	8/4/2021	P. Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 8/4/2021
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	5/7/2021	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 5/7/2021
GUD Knight Therapeutics	C$8.20	3/26/2021	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 3/26/2021
RX BioSyent	C$13.86 +0.2%	3/18/2021	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Accumulate ➝ Hold	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/18/2021
MDP Medexus Pharmaceuticals	C$3.91	2/23/2021	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 2/23/2021
MRVFF Nuvo Pharmaceuticals	C$0.98	11/17/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/17/2020
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	11/3/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Accumulate	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/3/2020
VMD Viemed Healthcare	$9.45 -0.3%	10/19/2020	P. Pandurangan Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of Viemed Healthcare (NASDAQ:VMD) on 10/19/2020
HTL Hamilton Thorne	C$1.45 +4.3%	8/21/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 8/21/2020
CRH CRH	$105.32 -1.1%	8/14/2020		Reiterated Rating		Buy	View details for Bloom Burton rating of CRH (NYSE:CRH) on 8/14/2020
XENE Xenon Pharmaceuticals	$53.72 +2.7%	8/13/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 8/13/2020
HLS HLS Therapeutics	C$4.40 -0.9%	7/21/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 7/21/2020
GUD Knight Therapeutics	C$8.20	6/29/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Accumulate	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 6/29/2020
ZYME Zymeworks	$24.36 +1.0%	6/14/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Zymeworks (NASDAQ:ZYME) on 6/14/2020
CPH Cipher Pharmaceuticals	C$16.55 -1.0%	5/8/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Accumulate	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/8/2020
HLS HLS Therapeutics	C$4.40 -0.9%	3/31/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Accumulate	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/31/2020
Before you buy SpaceX shares, consider this alternative approach (Ad) SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered. Discover the overlooked SpaceX IPO strategy before the June listing
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	3/19/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$23.00	Buy	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 3/19/2020
RX BioSyent	C$13.86 +0.2%	3/19/2020	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Accumulate	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/19/2020
MRVFF Nuvo Pharmaceuticals	C$0.98	11/12/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Buy	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/12/2019
GUD Knight Therapeutics	C$8.20	10/22/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 10/22/2019
HLS HLS Therapeutics	C$4.40 -0.9%	10/4/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Buy	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 10/4/2019
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	10/2/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 10/2/2019
RX BioSyent	C$13.86 +0.2%	8/26/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of BioSyent (CVE:RX) on 8/26/2019
CPH Cipher Pharmaceuticals	C$16.55 -1.0%	8/12/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/12/2019
HLS HLS Therapeutics	C$4.40 -0.9%	8/9/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Hold	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 8/9/2019
MDP Medexus Pharmaceuticals	C$3.91	7/3/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of Medexus Pharmaceuticals (TSE:MDP) on 7/3/2019
MRVFF Nuvo Pharmaceuticals	C$0.98	5/16/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Hold	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/16/2019
MRVFF Nuvo Pharmaceuticals	C$0.98	4/1/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 4/1/2019
HLS HLS Therapeutics	C$4.40 -0.9%	3/22/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of HLS Therapeutics (TSE:HLS) on 3/22/2019
CPH Cipher Pharmaceuticals	C$16.55 -1.0%	3/20/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 3/20/2019
CXRXF ADVANZ PHARMA	$17.06	3/15/2019	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for Bloom Burton rating of ADVANZ PHARMA (OTCMKTS:CXRXF) on 3/15/2019
GUD Knight Therapeutics	C$8.20	11/9/2018	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/9/2018
MRVFF Nuvo Pharmaceuticals	C$0.98	3/26/2018	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 3/26/2018
RX BioSyent	C$13.86 +0.2%	3/22/2018	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of BioSyent (CVE:RX) on 3/22/2018
EPI ESSA Pharma	C$8.20 +7.2%	1/18/2018	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Buy	View details for Bloom Burton rating of ESSA Pharma (CVE:EPI) on 1/18/2018
MRVFF Nuvo Pharmaceuticals	C$0.98	11/3/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Accumulate	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/3/2017
HTL Hamilton Thorne	C$1.45 +4.3%	10/25/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Hamilton Thorne (CVE:HTL) on 10/25/2017
CPH Cipher Pharmaceuticals	C$16.55 -1.0%	8/14/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Hold	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 8/14/2017
MRVFF Nuvo Pharmaceuticals	C$0.98	5/15/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Buy	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/15/2017
CPH Cipher Pharmaceuticals	C$16.55 -1.0%	5/12/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Hold ➝ Buy	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 5/12/2017
MRVFF Nuvo Pharmaceuticals	C$0.98	5/9/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Accumulate ➝ Hold	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 5/9/2017
CPH Cipher Pharmaceuticals	C$16.55 -1.0%	2/13/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Hold	View details for Bloom Burton rating of Cipher Pharmaceuticals (TSE:CPH) on 2/13/2017
RX BioSyent	C$13.86 +0.2%	2/13/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of BioSyent (CVE:RX) on 2/13/2017
ABUS Arbutus Biopharma	$4.23 -0.7%	1/9/2017	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Accumulate ➝ Buy	View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 1/9/2017
XENE Xenon Pharmaceuticals	$53.72 +2.7%	12/22/2016		Initiated Coverage	$14.50	Buy	View details for Bloom Burton rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 12/22/2016
ABUS Arbutus Biopharma	$4.23 -0.7%	12/14/2016	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of Arbutus Biopharma (NASDAQ:ABUS) on 12/14/2016
GUD Knight Therapeutics	C$8.20	11/10/2016	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of Knight Therapeutics (TSE:GUD) on 11/10/2016
AUPH Aurinia Pharmaceuticals	$15.78 +2.5%	11/4/2016	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for Bloom Burton rating of Aurinia Pharmaceuticals (NASDAQ:AUPH) on 11/4/2016
MRVFF Nuvo Pharmaceuticals	C$0.98	11/2/2016	D. Martin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Accumulate	View details for Bloom Burton rating of Nuvo Pharmaceuticals (OTCMKTS:MRVFF) on 11/2/2016
ACHV Achieve Life Sciences	$4.84 -3.8%	5/3/2013		Boost Price Target	$4,000.00 ➝ $5,000.00	Buy	View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/3/2013
ACHV Achieve Life Sciences	$4.84 -3.8%	3/8/2013		Boost Price Target	$3,600.00 ➝ $4,000.00		View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 3/8/2013
ONC Oncolytics Biotech	C$14.90 -1.3%	12/18/2012		Downgrade		Buy ➝ Hold	View details for Bloom Burton rating of Oncolytics Biotech (TSE:ONC) on 12/18/2012
ACHV Achieve Life Sciences	$4.84 -3.8%	5/4/2012		Lower Price Target	$3,800.00 ➝ $3,600.00	Buy	View details for Bloom Burton rating of Achieve Life Sciences (NASDAQ:ACHV) on 5/4/2012

MarketBeat Community Rating for Bloom Burton

MarketBeat's community ratings are surveys of what our community members think about Bloom Burton and other research firms in the last 90 days. Vote "Outperform" if you believe Bloom Burton's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Bloom Burton's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 2.6out of 5 (last 90 days)
2.6 of 5 stars
OUTPERFORM VOTES: 24 Believe will outperform the market
UNDERPERFORM VOTES: 23 Believe will underperform the market

Bloom Burton Stock Coverage by Sector

Bloom Burton concentrates its research most heavily in Medical (100.0%). The chart below shows how Bloom Burton's 5 rated companies are distributed across all 1 sector it covers.

Medical
5 companies
100.0%

Best & Worst Calls

Best Call
0000.0%
NASDAQ:EPIX
Reiterated Rating • May 24, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
000.0%
CVE:DOC
Reiterated Rating • Dec 22, 2021
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

Bloom Burton - Frequently Asked Questions

Bloom Burton's analysts currently have buy-equivalent ratings on 3 companies.

Bloom Burton has the deepest coverage in Medical (100.0% of rated companies).

Bloom Burton issued 5 ratings over the last 12 months across 5 companies â€” an average of roughly 0 rating actions per month. These include downgrade and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Bloom Burton analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?